Article Versions Notes

Mansier O, Prouzet-Mauléon V, Jégou G, Barroso K, Raymundo DP, Chauveau A, Dumas P-Y, Lagarde V, Turcq B, Pasquet J-M, et al. The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation. Cancers. 2019; 11(12):1921. https://doi.org/10.3390/cancers11121921

Mansier, Olivier, Valérie Prouzet-Mauléon, Gwénaële Jégou, Kim Barroso, Diana Pelizzari Raymundo, Aurélie Chauveau, Pierre-Yves Dumas, Valérie Lagarde, Béatrice Turcq, Jean-Max Pasquet, and et al. 2019. "The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation" Cancers 11, no. 12: 1921. https://doi.org/10.3390/cancers11121921

Mansier, O., Prouzet-Mauléon, V., Jégou, G., Barroso, K., Raymundo, D. P., Chauveau, A., Dumas, P.-Y., Lagarde, V., Turcq, B., Pasquet, J.-M., Viallard, J.-F., James, C., Praloran, V., Voutetakis, K., Chatziioannou, A., Mahon, F.-X., Chevet, E., & Lippert, E. (2019). The Expression of Myeloproliferative Neoplasm-Associated Calreticulin Variants Depends on the Functionality of ER-Associated Degradation. Cancers, 11(12), 1921. https://doi.org/10.3390/cancers11121921